New hope for rare lung disease: experimental drug shows promise
NCT ID NCT00993408
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 34 times
Summary
This study tested an experimental drug called ACT-293987 in 43 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The trial first checked how a single dose affects blood flow in the lungs, then compared the drug to a placebo over 21 weeks to see if it improves exercise ability and other measures. The goal was to find out if the drug is safe and works well enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Respiratory Medicine, Hannover Medical School
Hanover, 30625, Germany
-
Gasthuisberg University Hospital, Pneumology
Leuven, 3000, Belgium
-
Hammersmith Hospital
London, W12 0HS, United Kingdom
-
Hopital Antoine Beclere, Pneumologie
Paris, France
-
Hospital Sant'Orsola Malpighi, Cardiology's Department
Bologna, 40138, Italy
-
Instytut Gruzilcy i Chorob Pluc, Klinika Chorob Wewnetrznych Klatki Piersiowej
Warsaw, 01-138, Poland
-
Medizinische Universitat Wien, Universitatsklinik fur Innere Medizin II, Kardiologie
Vienna, 1090, Austria
-
Semmelweis University, Clinic of Pulmonology
Budapest, H-1125, Hungary
Conditions
Explore the condition pages connected to this study.